...
首页> 外文期刊>Medical principles and practice: international journal of the Kuwait University, Health Science Centre >Effect of intramuscular and intravenous lidocaine on propofol induction dose.
【24h】

Effect of intramuscular and intravenous lidocaine on propofol induction dose.

机译:肌肉和静脉注射利多卡因对异丙酚诱导剂量的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Our purpose was to study whether or not intravenous (IV) administration of lidocaine reduces propofol dose requirement as intramuscular (IM) lidocaine in a placebo-controlled manner. SUBJECTS AND METHODS: Seventy-five adult patients with American Society of Anesthesiologists physical status I and II, aged 20-60 years who were scheduled for surgery under general anaesthesia were included in the study. The patients were randomly allocated to 3 groups: IM: intramuscular administration; IV: intravenous administration and C: control. There were 25 patients in each group. The patients in group IM received lidocaine 1.5 mg . kg(-1) administered into the deltoid muscle 10 min before anaesthesia induction. In group IV, the patients received IV lidocaine 1.5 mg . kg(-1), 2 min before anaesthesia induction. Group C patients served as control group who received only propofol injection. Hypnosis after propofol administration was measured with response to verbal commands. RESULTS: There were no statistical differences between group IM (100.8 +/- 26.1 mg) and group IV (110.8 +/- 30.1 mg) regarding the induction dose of propofol (p > 0.05). In group C, the required propofol dose (151.2 +/- 27.4 mg) for anaesthesia induction was significantly higher than in the other groups (p < 0.001). No side effect was observed in any patients. CONCLUSION: In this study, both IV and IM lidocaine administration were effective in reducing the hypnotic dose of propofol without any side effects. In addition, IV lidocaine may be more comfortable for awake patients.
机译:目的:我们的目的是研究以安慰剂控制的方式静脉注射利多卡因(IV)是否可以降低异丙酚的剂量(肌注利多卡因)。研究对象和方法:年龄为20至60岁的75名美国麻醉医师协会I和II身体状况成人患者,他们计划在全身麻醉下进行手术。将患者随机分为3组:IM:肌肉注射; IV:静脉内给药,C:对照。每组25例。 IM组的患者接受利多卡因1.5 mg。在麻醉诱导前10分钟将10 kg(-1)注射到三角肌中。在IV组中,患者接受1.5mg利多卡因IV。 kg(-1),麻醉诱导前2分钟。 C组患者作为对照组,仅接受异丙酚注射。丙泊酚给药后的催眠反应是根据口头命令进行的。结果:关于异丙酚的诱导剂量,IM组(100.8 +/- 26.1 mg)和IV组(110.8 +/- 30.1 mg)之间没有统计学差异(p> 0.05)。在C组中,麻醉诱导所需的异丙酚剂量(151.2 +/- 27.4 mg)显着高于其他组(p <0.001)。在任何患者中均未观察到副作用。结论:在这项研究中,IV和IM利多卡因给药均有效降低了异丙酚的催眠剂量,而没有任何副作用。此外,IV利多卡因对于清醒患者可能更舒适。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号